Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ProPhase Labs Inc (NASDAQ:PRPH)

1.50
Delayed Data
As of 10:03am ET
 +0.001 / +0.07%
Today’s Change
1.21
Today|||52-Week Range
1.70
+2.81%
Year-to-Date
No recent news for ProPhase Labs Inc.

Today’s Trading

Previous close1.50
Today’s open1.52
Day’s range1.50 - 1.52
Volume550
Average volume (3 months)38,053
Market cap$23.8M
Dividend yield--
Data as of 10:03am ET, 07/30/2015

Growth & Valuation

Earnings growth (last year)-1,666.67%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-11.83%
P/E ratioNM
Price/Sales1.11
Price/Book2.22

Competitors

 Today’s
change
Today’s
% change
CYCCCyclacel Pharmaceuti...-0.03-3.75%
NVGNNovogen Ltd-0.11-3.05%
CLRBCellectar Bioscience...+0.13+4.25%
ABIOARCA Biopharma Inc-0.04-3.33%
Data as of 12:00pm ET, 07/30/2015

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$22.1M
Annual profit (last year)-$7.8M
Net profit margin-35.50%

Profile

Sector
Consumer Non-Durables
Industry
Household/Personal Care
Chairman, CEO &
Head-Investor Relations
Ted William Karkus
Chief Operating Officer &
Chief Financial Officer
Robert V. Cuddihy
Corporate headquarters
Doylestown, Pennsylvania

Forecasts